Immedica Pharma AB

Did you know that over 350 million people globally are living with a rare disease? Despite their significant impact, rare diseases often face limited awareness, delayed diagnoses, and insufficient resources for patient care. At Immedica, we recognize that raising awareness is a critical step in addressing the challenges of rare diseases. By increasing understanding and fostering dialogue, we can help bridge the gaps in knowledge and support needed to improve outcomes for patients and their families. Key facts about rare diseases: Over 7,000 rare diseases have been identified globally. 80% of rare diseases have a genetic origin. On average, it takes 5-7 years to receive an accurate diagnosis. Learn more about rare diseases om www.immedica.com

Celebrating Immedica's Partner Survey Results! We are excited to share the fantastic feedback from our Annual Partner Survey! At Immedica, our commitment to building strong, collaborative partnerships is at the heart of what we do, and it’s inspiring to see that reflected in the responses. Here are some highlights from the survey: ✨ 9/10 partners say it is likely or very likely they would recommend Immedica as a business partner. ✨ Overall satisfaction: Scored 3.8/4, reflecting consistent excellence in our ability to meet our partners’ needs and expectations. ✨ Trustworthiness: Rated a perfect 4/4, showcasing how much our partners rely on and respect the way we conduct business. We are grateful to our partners for their collaboration and trust as we continue working together to make a difference. #Partnership #Collaboration #Excellence #RareDiseases #ImmedicaPharma

Our team look forward to joining Jefferies London Healthcare Conference 2024 taking place November 19–21. This year’s gathering marks the 15th anniversary of the largest healthcare-dedicated conference in Europe and will bring together leading executives to address near-and long-term investment opportunities as well as the current trends driving healthcare in the U.S. and internationally. #JefferiesHealthcare

We're #hiring a new Associate Medical Affairs Manager in Stockholm, Stockholm County. Apply today or share this post with your network.

Join Our Team at Immedica! We’re looking for a dynamic Associate Medical Affairs Manager to join our growing team on a 1-year temporary position starting in January 2025. At Immedica, we are dedicated to making a difference in the lives of people living with rare diseases across Europe, the Middle East, and the US. This is an exciting opportunity for someone with 1-2 years of pharmaceutical industry experience who thrives in a fast-paced, evolving environment and enjoys working cross-functionally. Read more a bout the role here: https://lnkd.in/esyW_Snu #MedicalAffairs #RareDiseases #Immedica

We're thrilled to welcome Benjamin Owens to the Immedica team. With a strong background in life sciences and a track record of driving growth and strategic partnerships, Ben will lead our global business development efforts as we expand our global footprint. “We’re excited to have Ben’s expertise and vision as we push forward with our mission to deliver innovative therapies to underserved patient populations worldwide,” says Anders Edvell, CEO of Immedica. 🔗 Read more here: https://lnkd.in/ecmKh4WA

We’re thrilled to announce that Immedica has once again been certified as a Great Place to Work®! Thanks to our incredible team, our global survey results showed a Trust Index of 95% and 97% for the Swedish organization. These results reflect the dedication and commitment of our team across all regions, and we couldn't be prouder of what we’ve accomplished together. Thank you to everyone at Immedica for making this possible! #Immedica #ImmedicaPharma #GreatPlacetoWork #TrustIndex #Pharma

Immedica is thrilled to be attending the XIII Congress of the Latin American Society for Inborn Errors of Metabolism and Newborn Screening (SLEIMPN), taking place from October 22nd to 25th in Punta del Este, Uruguay. If you would like to meet with us during the event, please reach out to jenny.wuori@immedica.com. We look forward to engaging in insightful discussions and fostering meaningful collaborations! #RareDiseases # SLEIMPN #Immedica #InbornErrors #NewbornScreening

Immedica will be attending the EANM 2024 Congress from October 19–23 in Hamburg! This annual event, hosted by the European Association of Nuclear Medicine, brings together leading experts, researchers, and innovators in nuclear medicine from around the world. We look forward to sharing insights and learning about the latest developments in the field, and we welcome the opportunity to connect with industry professionals during the congress.   If you’re attending, don’t hesitate to reach out—we’d love to meet you there! #EANM2024 #NuclearMedicine #Immedica #Pharma EANM 2024 Congress | October 19–23, 2024

We are present at #cphi2024 in Milan, October 8-10. Meet us there!